It reduces the expression of IL-1β in gingiva and has significant anti-inflammatory and bone-protective effects in Wistar rats with experimental periodontitis.165 Bortezomib, a proteasome inhibitor, is used as an anticancer drug. This evidence concerns the gene IL1B and periodontitis.